Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro™ to ... PR Newswire (press release) HORSHOLM, Denmark, May 20, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the STRATO study demonstrates the potential for LCP-Tacro™ to improve tacrolimus-induced tremors in stable kidney ... |
